Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infectious Diseases and Therapy
Published in: Infectious Diseases and Therapy 2/2013

Open Access 01-12-2013 | Review

The Problems with Polio: Toward Eradication

Authors: Gemma Lien, David L. Heymann

Published in: Infectious Diseases and Therapy | Issue 2/2013

Login to get access

Abstract

The global health effort to eradicate poliomyelitis (polio) has encountered a number of unforeseen and unpredictable challenges. This article provides a timely review of progress made toward eradication, including the polio vaccines in use, and explores the reasons for delays in eradication target dates. It provides an overview of some of the remaining barriers to eradication and looks toward overcoming these through the Polio Eradication and Endgame Strategic Plan.
Literature
1.
Aylward B, Tangermann R. The global polio eradication initiative: lessons learned and prospects for success. Vaccine. 2011;29:D80–5.PubMedCrossRef
2.
3.
Bunimovich-Mendrazitsky S, Stone L. Modeling polio as a disease of development. J Theor Biol. 2005;237:302–15.PubMedCrossRef
4.
5.
6.
7.
8.
Grassly N, Wenger J, Durrani S, Bahl S, Deshpande J, Sutter R, et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case–control study. Lancet. 2007;369:1356–62.PubMedCrossRef
9.
Sutter R, John T, Jain H, Agarkhedkar S, Ramanan P, Verma H, et al. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomized, double-blind, controlled trial. Lancet. 2010;376:1682–8.PubMedCrossRef
10.
Heymann D, Sutter R, Aylward B. A vision of a world without polio: the OPV cessation strategy. Biologicals. 2006;34:75–9.PubMedCrossRef
11.
12.
13.
Aylward B, Acharya A, England S, Agocs M, Linkins J. Global health goals: lessons from the worldwide effort to eradicate poliomyelitis. Lancet. 2003;362:909–14.PubMedCrossRef
14.
15.
16.
Transmission of wild poliovirus type 2: apparent global interruption. Wkly Epidemiol Record. 2001;76(13):95–97.
17.
Grassly N, Fraser C, Wenger J, Deshpande J, Sutter R, Heymann D, et al. New strategies for the elimination of polio from India. Science. 2006;314:1150–3.PubMedCrossRef
18.
19.
John T, Vashishtha V. Eradicating poliomyelitis: India’s journey from hyperendemic to polio-free status. Indian J Med Res. 2013;137(5):881–94.PubMedCentralPubMed
20.
21.
22.
23.
24.
Thompson K, Duintjer Tebbens R. Eradication versus control for poliomyelitis: an economic analysis. Lancet. 2007;369 (9570):1363–71.
25.
Duintjer Tebbens R, Pallansch M, Cochi S, Wassilak S, Linkins J, Sutter R, et al. Economic analysis of the global polio eradication initiative. Vaccine. 2011;29(2):334–43.
26.
27.
28.
29.
30.
31.
32.
33.
34.
Heymann D, Fine P, Griffiths U, Hall A, Mounier-Jack S. Measles eradication: past is prologue. Lancet. 2010;376:1719.PubMedCrossRef
Metadata
Title
The Problems with Polio: Toward Eradication
Authors
Gemma Lien
David L. Heymann
Publication date
01-12-2013
Publisher
Springer Healthcare
Published in
Infectious Diseases and Therapy / Issue 2/2013
Print ISSN: 2193-8229
Electronic ISSN: 2193-6382
DOI
https://doi.org/10.1007/s40121-013-0014-6

Other articles of this Issue 2/2013

Infectious Diseases and Therapy 2/2013 Go to the issue

Original Research

Amikacin Pharmacokinetics During Continuous Veno-Venous Hemodialysis

Review

Is Community-Acquired Methicillin-Resistant Staphylococcus aureus Coverage Needed for Cellulitis?

Review

The Role of Human Beta-Defensin-2 in Pseudomonas aeruginosa Pulmonary Infection in Cystic Fibrosis Patients

Original Research

Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity

Review

Ceftaroline Fosamil: A Brief Clinical Review

Review

Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits